Supporting discovery and development of medical countermeasures for chemical injury to eye and skin
Open Access
- 15 June 2022
- journal article
- research article
- Published by Elsevier in Experimental Eye Research
- Vol. 221, 109156
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- Science for Equity, Empowerment and Development Division
- Centers for Disease Control and Prevention
- U.S. Food and Drug Administration
This publication has 32 references indexed in Scilit:
- Recent sulfur mustard attacks in Middle East and experience of health professionalsToxicology Letters, 2020
- Therapeutic options to treat mustard gas poisoning - Review.2019
- Advanced biotherapy for the treatment of sulfur mustard poisoningChemico-Biological Interactions, 2018
- Estimation of clinical trial success rates and related parametersBiostatistics, 2018
- Serendipity in Cancer Drug Discovery: Rational or Coincidence?Trends in Pharmacological Sciences, 2016
- Innovation in the pharmaceutical industry: New estimates of R&D costsJournal of Health Economics, 2016
- Identification and validation of vesicant therapeutic targets using a high-throughput siRNA screening approachArchives of Toxicology, 2014
- A review on delayed toxic effects of sulfur mustard in Iranian veteransDARU Journal of Pharmaceutical Sciences, 2012
- The effect of Nigella sativa alone, and in combination with dexamethasone, on tracheal muscle responsiveness and lung inflammation in sulfur mustard exposed guinea pigsJournal of Ethnopharmacology, 2011
- The art and practice of structure-based drug design: A molecular modeling perspectiveMedicinal Research Reviews, 1996